Американское общество гирудотерапии

Ciprofloxacin-resistant Aeromonas infection following leech therapy for digit replantation: report of 2 cases

van Alphen NA, Gonzalez A, McKenna MC, McKenna TK, Carlsen BT, Moran SL (2014) · Journal of Hand Surgery · n=2

RCT evidence detailTrial reference
Sample size of this trial compared with other Microsurgical Replantation (Digit / Ear / Scalp) trialsArbel EJ 202446Battin AO 202312Hong Ha N 20254van Alphen NA 20142Akhoondinasab MR 20231Banihani OI 20141Mousa A 20221Mendenhall SD 20161Momeni A 20141Senchenkov A 20131
This trial (highlighted) by sample size alongside other indexed Microsurgical Replantation (Digit / Ear / Scalp) trials. Larger trials generally carry more statistical weight.

Study Profile

Design
two-case report (Mayo Clinic Rochester, cases occurring within 4 months of each other)
Sample size (n)
2
Intervention
Leech therapy after unsuccessful digital replantation in patients with subsequent ciprofloxacin-resistant Aeromonas hydrophila infection
Comparator
Historical Mayo Clinic protocol with ciprofloxacin or TMP-SMX prophylaxis
Primary endpoint
Infection characteristics, antibiotic resistance patterns, and treatment outcomes
Primary result
Both cases successfully treated with ceftriaxone after failure of ciprofloxacin prophylaxis; documents emerging ciprofloxacin-resistant Aeromonas strains in replantation center setting
Follow-up duration
Infection resolution

Key Findings

  • Two ciprofloxacin-resistant Aeromonas cases within 4 months
  • Ceftriaxone successful as rescue antibiotic
  • Documents emerging resistance to first-line prophylaxis
  • Replantation centers should monitor local Aeromonas susceptibility
  • Antibiogram-guided prophylaxis selection recommended

Limitations

  • Only 2 cases - cannot quantify resistance prevalence
  • Single replantation center experience
  • Cannot determine if cases share common Aeromonas source
  • Limited microbiologic characterization of resistance mechanism
  • Cannot recommend universal protocol changes

Clinical Implications

van Alphen 2014 documents emerging ciprofloxacin-resistant Aeromonas at a major US replantation center, supporting periodic local antibiogram review and consideration of ceftriaxone as backup. For US clinicians under K040187, this Mayo Clinic case series reinforces antimicrobial stewardship principles and the dynamic nature of resistance profiles in leech-treated populations.

Related Trials

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.